Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT
Study Details
Study Description
Brief Summary
The purpose of this study is to test the effectiveness of evidence-informed mobile apps, Myeloma Coach and CLL Coach. These apps have been developed to help manage the physical and emotional symptoms experienced by multiple myeloma and chronic lymphocytic leukemia survivors. This study hopes to determine if a mobile app is a useful tool to help people manage commonly reported symptoms related to Multiple Myeloma (MM) and chronic lymphocytic leukemia (CLL).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Myeloma Coach or CLL Coach Mobile App Participants diagnosed with Multiple Myeloma will use the Myeloma Coach app and participants diagnosed with CLL (chronic lymphocytic leukemia) will use the the CLL Coach app. Pattern Health apps are built around "patterns" of scheduled activities. Users will encounter a list of activities to engage with for the day. There is also an option to complete activities in an ad hoc fashion. |
Other: Myeloma Coach or CLL Coach Mobile App
Symptom Tracking: Subjects will be asked to track their symptoms on a weekly basis, as well as given the opportunity to track these symptoms whenever they would like. Subjects will receive feedback tailored to their symptom severity with coaching on self management, including encouraging them to reach out to their health care team when symptoms are new, severe or increasing in severity. Subjects will also be able to look at graphs of symptom severity over time and share them with family and their health care team.
Medication Adherence Reminders and Tracking, Activities - tools based on CBT (cognitive behavioral therapy) principles can be utilized at any time to manage emotional distress. Learn - information on cancer, its treatment, self managing physical and emotional symptoms, and supportive resources.
|
| Placebo Comparator: Springboard Beyond Cancer informational website
|
Other: Springboard Beyond Cancer informational website
Springboard Beyond Cancer (https://survivorship.cancer.gov) is designed to make it easy for those in treatment and post-treatment to access essential information to help them manage ongoing cancer-related symptoms, deal with stress, improve healthy behaviors, communicate better with healthcare teams, and seek support from friends and family.
|
Outcome Measures
Primary Outcome Measures
- Change in Edmonton Symptom Assessment Scale (ESAS) [Baseline, 4 weeks, 8 weeks]
The ESAS is a validated 10 item survey index used to assessed symptoms. The total ranges from 0 to 60, with a higher score indicating higher physical symptom burden.
- Change in NCCN Distress Thermometer [Baseline, 4 weeks, 8 weeks]
The NCCN Distress Thermometer (DT) is a one-item, 11-point Likert scale represented on a visual graphic of a thermometer that ranges from 0 (no distress) to 10 (extreme distress), with which patients indicate their level of distress over the course of the week prior to assessment.
- Change in PROMIS (Patient-Reported Outcomes Measurement Information System) Short Form Global Health [Baseline, 4 weeks, 8 weeks]
This validated 10 item survey captures a person's self assessment of their global physical and global mental health. The possible score ranges from 0 to 20 points in each case. 0 points represent the patient's most severe physical and/or mental impairment, while 20 points represent the best possible state of health.
- Change in severity of PTSD related symptoms as measured by PTSD Checklist (PCL5) [Baseline, 4 weeks, 8 weeks]
This validated 20 item measure has been used extensively in research. Scores consist of a total symptom severity score (from 0 to 80) from four subscales: Re-experiencing (items 1-5 - max score = 20), Avoidance (items 6-7 - max score = 8), Negative alterations in cognition and mood (items 8-14 - max score = 28), and Hyper-arousal (items 15-20 - max score = 24). Higher scores represent higher severity.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Be at least 18 years of age;
-
Be a resident of the United States of America;
-
Be able to read and write English
-
Consistent access to the internet via a smartphone, tablet or computer
-
Have a diagnosis of multiple myeloma or chronic lymphocytic leukemia
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Duke University | Durham | North Carolina | United States | 27708 |
Sponsors and Collaborators
- Duke University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00105025